Taltz 80 MG/ML autoinjectorml
Ended Awarded Last action
- Contract number
- SPE2DR26F3G0F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,511
Award facts
- Contract value 100% obligated
- $11,510.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $11,510.81 firm fixed price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on January 5, 2026, with an ultimate completion date of January 6, 2026. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant used primarily to treat autoimmune inflammatory conditions such as psoriasis and rheumatoid arthritis.
As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp fulfills a broad portfolio of pharmaceutical and medical supply needs across military and veteran healthcare systems. The company's comprehensive IDC vehicle enables the supply of specialty medications, brand-name and generic drugs, vaccines, and medical devices to support Defense Health Agency operations and other federal healthcare programs globally. This delivery order exemplifies the routine pharmaceutical procurement executed through AmerisourceBergen's established relationship with DLA, supporting ongoing medical supply chain requirements for federal healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F3G0F?
SPE2DR26F3G0F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26F3G0F worth?
The government has obligated $11,511 on SPE2DR26F3G0F.
Is contract SPE2DR26F3G0F an order under another contract?
Yes. SPE2DR26F3G0F is a delivery order under SPE2DR25D3001, an indefinite delivery contract.
Was contract SPE2DR26F3G0F competed?
The extent of competition for SPE2DR26F3G0F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award